Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging.

导出 OA

翻译打印收藏纠错

作者： Rahul,Vyas ^[1] ; Viraj,Panchal ^[2] ; Shubhika,Jain ^[3] ; Manush,Sondhi ^[1] ; Mansunderbir,Singh ^[1] ; Keerthish,Jaisingh ^[4] ; Sahith Reddy,Thotamgari ^[4] ; Anuj,Thakre ^[1] ; Kalgi,Modi ^[4]

作者单位： Department of Internal Medicine, Louisiana State University, Shreveport, Louisiana, United States of America. ^[1] Department of Medicine, Smt. NHL Municipal Medical College and SVPISMR, Ahmedabad, Gujarat, India. ^[2] Department of Medicine, Kasturba Medical College, Manipal, Karnataka, India. ^[3] Department of Cardiology, Louisiana State University, Shreveport, Louisiana, United States of America. ^[4]

主题词人类(Humans);心肌病, 肥厚性(Cardiomyopathy, Hypertrophic);心脏(Heart);苄胺类(Benzylamines);尿嘧啶(Uracil)

DOI 10.1371/journal.pone.0301704

PMID 38635724

发布时间 2024-04-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交